Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
Warning: file_get_contents(http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=18799446&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 445
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Neurologic manifestations of von Hippel-Lindau disease Butman JA; Linehan WM; Lonser RRJAMA 2008[Sep]; 300 (11): 1334-42von Hippel-Lindau disease (VHL) is an autosomal-dominant neoplasia syndrome that is the result of a germline mutation of the VHL tumor suppressor gene on the short arm of chromosome 3. Patients with VHL are predisposed to develop lesions of the central nervous system and viscera. Central nervous system lesions include hemangioblastomas (the most common tumor in VHL) and endolymphatic sac tumors (ELSTs). Visceral manifestations include renal carcinomas and cysts, pancreatic neuroendocrine tumors and cysts, pheochromocytomas, and cystadenomas of the reproductive adnexal organs. Despite their benign pathology, hemangioblastomas and ELSTs are a frequent cause of morbidity and mortality in patients with VHL. Recent molecular biologic investigations into these VHL-associated central nervous system lesions provide new insight into their origin and development. Emerging data from serial imaging and clinical surveillance protocols provide insight into the natural history of these lesions. Because of the dissimilar pathobiology and clinical course between hemangioblastomas and ELSTs, the optimal management strategies for these neurologic manifestations of VHL are very different.|*Endolymphatic Sac[MESH]|Adult[MESH]|Carcinoma, Renal Cell/diagnosis/etiology/surgery[MESH]|Central Nervous System Neoplasms/diagnosis/*etiology/surgery[MESH]|Disease Progression[MESH]|Ear Neoplasms/diagnosis/*etiology/surgery[MESH]|Female[MESH]|Hearing Loss, Sensorineural/etiology[MESH]|Hemangioblastoma/diagnosis/*etiology/surgery[MESH]|Humans[MESH]|Kidney Neoplasms/diagnosis/etiology/surgery[MESH]|Pancreatic Cyst/diagnosis/etiology[MESH]|Von Hippel-Lindau Tumor Suppressor Protein/genetics[MESH]|von Hippel-Lindau Disease/*complications/*diagnosis[MESH] |
